Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-003025
Filing Date
2020-01-10
Accepted
2020-01-10 16:01:04
Documents
1
Period of Report
2020-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8768
  Complete submission text file 0001209191-20-003025.txt   10210
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Shoemaker Daniel D (Reporting) CIK: 0001586892 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36076 | Film No.: 20521062